(3β,6α,12β)-20-(β-<SC>D</SC>-葡萄糖基吡喃糖基氧基)-3,12-二羟基达玛-24-烯-6-基 2-<I>O</I>-(6-脱氧-α-<SC>L</SC>-甘露吡喃糖基)-β-<SC>D</SC>-吡喃葡萄糖苷

产品名称：

52286-59-6
Ginsenoside Re
Chikusetsusaponin IVc
NSC 308877
Panaxoside Re
Sanchinoside Re
(3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
Ginsenoside B2
人参皂苷Re
(3β,6α,12β)-20-(β-D-葡萄糖基吡喃糖基氧基)-3,12-二羟基达玛-24-烯-6-基 2-O-(6-脱氧-α-L-甘露吡喃糖基)-β-D-吡喃葡萄糖苷
人参皂苷B2
竹节参皂苷IVc
三七皂苷Re

产品介绍：

产品说明

一般描述

Produced and qualified by HWI pharma services GmbH.
Exact content by quantitative NMR can be found on the certificate.

应用

Reference Standard in the analysis of herbal medicinal products

基本信息

经验(实验)分子式	C₄₈H₈₂O₁₈
分子量	947.15
NACRES	NA.24

产品性质

等级	primary reference standard
保质期	limited shelf life, expiry date on the label
manufacturer/tradename	HWI
application(s)	food and beverages
SMILES string	CC1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@H]3C[C@]4(C)[C@H](C[C@@H](O)[C@@H]5[C@H](CC[C@@]45C)[C@](C)(CC\C=C(/C)C)O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@]7(C)CC[C@H](O)C(C)(C)[C@H]37)[C@H](O)[C@H](O)[C@H]1O
InChI	1S/C48H82O18/c1-21(2)11-10-14-48(9,66-42-38(60)35(57)32(54)26(19-49)63-42)23-12-16-46(7)30(23)24(51)17-28-45(6)15-13-29(52)44(4,5)40(45)25(18-47(28,46)8)62-43-39(36(58)33(55)27(20-50)64-43)65-41-37(59)34(56)31(53)22(3)61-41/h11,22-43,49-60H,10,12-20H2,1-9H3/t22-,23-,24+,25-,26+,27+,28?,29-,30+,31-,32+,33+,34+,35?,36-,37+,38+,39+,40-,41-,42-,43+,45+,46+,47+,48-/m0/s1
InChI key	PWAOOJDMFUQOKB-QVPADXGFSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302
预防措施声明	P264 - P270 - P301 + P312 - P501
危险分类	Acute Tox. 4 Oral
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable